4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-359675
Co-Chief Executive Officer acquired 60,039 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Joshua B Co-Chief Executive Officer | 2026-08-18 | Grant or award | +60,039 | 3,643,587 | D |
Loading xslF345X06/ownership.xml…